Bladder Cancer News
Online misinformation is harming cancer patients. YouTube has been part of the problem, but a new policy might change that.
Prostate cancer patients treated with radiotherapy have a higher risk of developing and dying from bladder cancer or lung cancer than patients treated with radical prostatectomy alone, a study suggests.
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
A new study suggests that electronic health records could be better tailored to meet the specific needs of oncologists.
Cancer deaths increased during the first 2 years of the COVID-19 pandemic in the United States, a population-based study suggests.
Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.
New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Cancer patients with ICI-induced acute pancreatitis may require abdominal imaging for diagnosis and monitoring for exocrine pancreatic insufficiency.
Patients with current or past cancer have a higher prevalence of acute myocardial infarction as the cause of chest pain than patients without cancer.
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Pharmaceutical experts review ocular adverse effects related to antibody-drug conjugates.
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Ocular side effects of immune checkpoint inhibitors are considered rare but may be underreported.
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Adding durvalumab to standard treatment for resectable, muscle-invasive urothelial carcinoma produces promising outcomes, according to researchers.
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.